In this session, Dr. Cheshire will discuss how to accurately assess patients in pain, develop a safe and effective pain treatment plan, identify evidence-based non-opioid options for the treatment of pain, and recognize behaviors that may be associated with opioid use disorder. Session participants will also learn to identify the risks and benefits of opioid therapy and how to manage ongoing therapy with patients.
This course meets the Drug Enforcement Agency (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) Medication Access and Training Expansion (MATE) Act. The Act requires new or renewing DEA registrants, as of June 27, 2023, to have completed a total of at least eight hours of training on opioid or other substance use disorders.